European Archives - Page 136 of 1169 - European Medical Journal

Seizure Risk in Alzheimer’s: High-Frequency Oscillations as a New Biomarker

High-frequency oscillations predict seizure risk in Alzheimer’s. Levetiracetam reduces them in epileptic patients but increases them in non-epileptic cases.

Early Menopause Raises Risk of ACPA-Negative Arthritis

A study revealed that early menopause and fewer reproductive years significantly increase the risk of ACPA-negative inflammatory arthritis.

Adolescent Mothers Benefit from Support in Breastfeeding

A study has found that adolescent mothers with strong social support have higher breastfeeding success and self-efficacy.

New Nomogram Predicts Microvascular Invasion in Patients with Hepatocellular Carcinoma

A new nomogram predicts microvascular invasion in patients with HCC, aiding preoperative decision-making and improving surgical outcomes.

Jade Williams and Isabel O'Brien, EMJ GOLD

Does interactivity boost memory, recall and retention?

Explore the science behind memory, recall and retention, and uncover why interactive content could be the future in this podcast.

Cytokine Markers Predict Mortality in Advanced HIV Cases

Researchers have identified key immunological markers associated with mortality in hospitalised people living with HIV/AIDS.

Faecal Calprotectin Predicts Inflammation in Crohn’s Disease

A new study in BMC Gastroenterology confirms that fecal calprotectin (FC) from ileostomy output is a highly sensitive biomarker for detecting small bowel inflammation in postoperative Crohn’s disease patients.

AI-Powered Sensor Helps Reduce Nocturnal Scratching

While numerous pharmacological treatments for atopic dermatitis exist, there is a scarcity of effective nonpharmacological interventions.

Whipple’s Disease: One of Medicine’s Great Imitators

Following an admission to the authors’ centre with severe anaemia, duodenal biopsy confirmed the diagnosis of Whipple’s disease…

FDA approves first at-home coeliac genetic test

A new at-home genetic test that assesses the risk of developing coeliac disease has received approval from US regulators.